Althea is an Australian licensed producer, supplier and exporter of pharmaceutical grade medicinal cannabis and is listed publicly on the Australian Securities Exchange (ASX:AGH).
Althea also offers a range of education, access and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways.
Althea currently operates within highly regulated medicinal cannabis markets including Australia and the United Kingdom, with plans to expand into emerging markets throughout Asia and Europe.
Althea goes above and beyond, ensuring patients are supplied with pharmaceutical grade, full spectrum, medicinal cannabis products. The safety, consistency and quality of Althea medicinal cannabis is ensured by its Seed-to-Sale* Certification – a strict quality management programme consisting of 509 individual steps used throughout the cultivation and manufacturing of Althea medicinal cannabis products. *Althea’s medicinal cannabis products are currently greenhouse grown and manufactured by Aphria Inc., a licensed Canadian producer of medicinal cannabis and part owner of Althea.